NO902802L - Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus. - Google Patents
Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.Info
- Publication number
- NO902802L NO902802L NO90902802A NO902802A NO902802L NO 902802 L NO902802 L NO 902802L NO 90902802 A NO90902802 A NO 90902802A NO 902802 A NO902802 A NO 902802A NO 902802 L NO902802 L NO 902802L
- Authority
- NO
- Norway
- Prior art keywords
- glycoproteins
- human respiratory
- gymoprotein
- chemical
- containing immunogenic
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 4
- 108090000288 Glycoproteins Proteins 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000711920 Human orthopneumovirus Species 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13738787A | 1987-12-23 | 1987-12-23 | |
PCT/US1988/003784 WO1989005823A1 (en) | 1987-12-23 | 1988-10-31 | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
Publications (3)
Publication Number | Publication Date |
---|---|
NO902802D0 NO902802D0 (no) | 1990-06-22 |
NO902802L true NO902802L (no) | 1990-06-22 |
NO300254B1 NO300254B1 (no) | 1997-05-05 |
Family
ID=22477194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO902802A NO300254B1 (no) | 1987-12-23 | 1990-06-22 | Fremgangsmåte for fremstilling av en vaksine mot humant respiratorisk syncytielt virus |
Country Status (14)
Country | Link |
---|---|
US (2) | US5194595A (no) |
EP (1) | EP0396563B1 (no) |
JP (1) | JP2716503B2 (no) |
KR (1) | KR0137963B1 (no) |
AT (1) | ATE85622T1 (no) |
AU (1) | AU617739B2 (no) |
CA (1) | CA1320163C (no) |
DE (1) | DE3878468T2 (no) |
DK (1) | DK173175B1 (no) |
FI (1) | FI102382B1 (no) |
HK (1) | HK166295A (no) |
MX (1) | MX9203458A (no) |
NO (1) | NO300254B1 (no) |
WO (1) | WO1989005823A1 (no) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
US6004563A (en) * | 1990-11-07 | 1999-12-21 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
US5824307A (en) * | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
GB9207479D0 (en) * | 1992-04-06 | 1992-05-20 | Scotgen Ltd | Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man |
TW275632B (no) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
CA2151597A1 (en) * | 1993-01-08 | 1994-07-21 | Robert L. Garlick | Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
US5723130A (en) * | 1993-05-25 | 1998-03-03 | Hancock; Gerald E. | Adjuvants for vaccines against respiratory syncytial virus |
US7300918B2 (en) | 1994-01-14 | 2007-11-27 | Matthias Rath | Method of producing vaccines from protein signal oligopeptides |
DE69534077T2 (de) * | 1994-01-14 | 2005-08-11 | Rath, Matthias, Dr.med. | Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden |
FR2718452B1 (fr) | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
WO1996010400A1 (en) * | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
FR2726472B1 (fr) | 1994-11-07 | 1997-01-31 | Pf Medicament | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin |
DE4442114A1 (de) * | 1994-11-25 | 1996-05-30 | Buna Sow Leuna Olefinverb Gmbh | Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel |
US5811524A (en) | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
US6015664A (en) * | 1995-11-03 | 2000-01-18 | Mcw Research Foundation | Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B |
AU6908598A (en) * | 1996-10-29 | 1998-05-22 | Smithkline Beecham Biologicals (Sa) | Purification of respiratory syncytial virus antigens |
US6103466A (en) * | 1997-07-14 | 2000-08-15 | University Of Liege | Double-muscling in mammals |
EP2045322B1 (en) | 1997-07-14 | 2015-07-01 | Université de Liège | Double-muscling in mammals |
US20070067859A1 (en) * | 1997-07-14 | 2007-03-22 | Michel Georges | Double-muscling in mammals |
US6699478B1 (en) * | 1997-09-19 | 2004-03-02 | Wyeth Holdings Corporation | Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus |
GB9909077D0 (en) | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
WO2001064751A2 (en) | 2000-03-01 | 2001-09-07 | Medimmune, Inc. | High potency recombinant antibodies and method for producing them |
DK1265928T3 (da) * | 2000-01-27 | 2010-11-15 | Medimmune Llc | RSV-neutraliserende antistoffer med ultra høj affinitet |
US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
DE602005018473D1 (de) * | 2004-05-24 | 2010-02-04 | Polymun Scient Immunbio Forsch | Superbeladene liposome für die arzneimittelabgabe |
JP2008518936A (ja) * | 2004-10-29 | 2008-06-05 | メディミューン,インコーポレーテッド | Rsv感染症および関連状態を予防および治療する方法 |
EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
SG188813A1 (en) | 2007-12-24 | 2013-04-30 | Id Biomedical Corp Quebec | Recombinant rsv antigens |
CN102131830A (zh) * | 2008-07-18 | 2011-07-20 | 魁北克益得生物医学公司 | 嵌合呼吸道合胞病毒多肽抗原 |
AU2010264688A1 (en) | 2009-06-24 | 2012-01-19 | Glaxosmithkline Biologicals S.A. | Recombinant RSV antigens |
HRP20220756T1 (hr) | 2009-07-15 | 2022-09-02 | Glaxosmithkline Biologicals S.A. | Proteinski pripravci rsv f i postupci za izradu istih |
US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
JP6523955B2 (ja) | 2012-08-01 | 2019-06-05 | バヴァリアン・ノルディック・アクティーゼルスカブ | 組換え改変ワクシニアウイルスアンカラ(mva)rsウイルス(rsv)ワクチン |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4855224A (en) * | 1984-03-09 | 1989-08-08 | Genentech, Inc. | Molecularly cloned diagnostic product and method of use |
JPH01501357A (ja) * | 1986-01-14 | 1989-05-18 | ユニバ−シテイ・オブ・ノ−ス・カロライナ | ヒト呼吸器系ウイルス用ワクチン |
US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
US5001230A (en) * | 1988-02-18 | 1991-03-19 | Schering Corporation | T cell activation markers |
SG106639A1 (en) * | 2000-10-10 | 2004-10-29 | Gen Electric | Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating |
-
1988
- 1988-10-31 DE DE8888909879T patent/DE3878468T2/de not_active Expired - Lifetime
- 1988-10-31 MX MX9203458A patent/MX9203458A/es unknown
- 1988-10-31 KR KR1019890701589A patent/KR0137963B1/ko not_active IP Right Cessation
- 1988-10-31 AT AT88909879T patent/ATE85622T1/de not_active IP Right Cessation
- 1988-10-31 US US07/543,780 patent/US5194595A/en not_active Expired - Lifetime
- 1988-10-31 WO PCT/US1988/003784 patent/WO1989005823A1/en active IP Right Grant
- 1988-10-31 JP JP63509171A patent/JP2716503B2/ja not_active Expired - Lifetime
- 1988-10-31 EP EP88909879A patent/EP0396563B1/en not_active Expired - Lifetime
- 1988-10-31 AU AU27850/89A patent/AU617739B2/en not_active Expired
- 1988-11-07 CA CA000582378A patent/CA1320163C/en not_active Expired - Lifetime
-
1990
- 1990-06-21 FI FI903154A patent/FI102382B1/fi not_active IP Right Cessation
- 1990-06-22 DK DK199001532A patent/DK173175B1/da not_active IP Right Cessation
- 1990-06-22 NO NO902802A patent/NO300254B1/no not_active IP Right Cessation
-
1992
- 1992-11-20 US US07/979,505 patent/US5288630A/en not_active Expired - Lifetime
-
1995
- 1995-10-26 HK HK166295A patent/HK166295A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5194595A (en) | 1993-03-16 |
JP2716503B2 (ja) | 1998-02-18 |
KR0137963B1 (ko) | 1998-04-30 |
DE3878468D1 (de) | 1993-03-25 |
JPH03501723A (ja) | 1991-04-18 |
NO300254B1 (no) | 1997-05-05 |
NO902802D0 (no) | 1990-06-22 |
FI102382B (fi) | 1998-11-30 |
CA1320163C (en) | 1993-07-13 |
HK166295A (en) | 1995-11-03 |
WO1989005823A1 (en) | 1989-06-29 |
KR900700508A (ko) | 1990-08-13 |
MX9203458A (es) | 1992-09-01 |
DK153290D0 (da) | 1990-06-22 |
DE3878468T2 (de) | 1993-06-09 |
US5288630A (en) | 1994-02-22 |
AU2785089A (en) | 1989-07-19 |
DK153290A (da) | 1990-08-16 |
ATE85622T1 (de) | 1993-02-15 |
FI102382B1 (fi) | 1998-11-30 |
DK173175B1 (da) | 2000-03-06 |
AU617739B2 (en) | 1991-12-05 |
EP0396563B1 (en) | 1993-02-10 |
EP0396563A1 (en) | 1990-11-14 |
FI903154A0 (fi) | 1990-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO902802D0 (no) | Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus. | |
NO904538L (no) | Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3. | |
BR1101088A (pt) | Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura | |
EE9900343A (et) | Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon | |
EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
DE60041280D1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
HK51597A (en) | Vaccines for human respiratory virus | |
KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
ATE234917T1 (de) | Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung | |
DK0892054T3 (da) | Clostridium perfringens-vaccine | |
DK311485D0 (da) | Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin | |
ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
DE3064590D1 (en) | Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it | |
DE3582422D1 (de) | Biologische zubereitungen. | |
ATE15501T1 (de) | Impfstoff fuer gefluegel gegen ansteckende bronchitis, zusammengesetzte impfstoffe gegen ansteckende bronchitis, verfahren zu deren herstellung und virusstamm der ansteckenden bronchitis. | |
EP1082011A4 (en) | AVIAN POLYOMA VIRUS VACCINES FOR PSITTACIDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |